Conditional fibroblast-specific deletion of type 2 transforming growth factor beta receptor replicates digital contractures of late-stage scleroderma.
CP Denton(The Royal Free Hospital), Casilda G. Black, Patricio Clark Di Leoni, SW Xu, K. Khan, Dietmar Abraham(Medical University of Vienna)
UCL Discovery (University College London)
September 1, 2005
Cited by 0
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation
|Journal of Biological Chemistry|2000|219
Open-Label Trial of Anti-TNF-α in Dermato- and Polymyositis Treated Concomitantly with Methotrexate
|European Neurology|2008|99